IDiyas

For the Inventor, By the Inventor

Watertown, MA, United States of America

Rajeswari Sundaramoorthi

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 8.3

ph-index = 10

Forward Citations = 205(Granted Patents)


Location History:

  • Chennai, IN (2011 - 2013)
  • Watertown, MA (US) (2002 - 2016)

Company Filing History:

goldMedal19 out of 69 
 
Ariad Pharmaceuticals, Inc.
 patents

Years Active: 2002-2016

where 'Filed Patents' based on already Granted Patents

19 patents (USPTO):
1. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors (2016-03-08),
2. 9090561 - Acetylenic heteroaryl compounds (2015-07-28),
3. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors (2015-05-12),
4. 8778942 - Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitors (2014-07-15),
5. 8586566 - Unsaturated heterocyclic derivatives (2013-11-19),
6. 8470851 - Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors (2013-06-25),
7. 8461167 - Acetylenic heteroaryl compounds (2013-06-11),
8. 8278307 - Monocyclic Heteroaryl compounds (2012-10-02),
9. 8114874 - Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors (2012-02-14),
10. 8071609 - Unsaturated heterocyclic derivatives (2011-12-06),
11. 7132427 - Quinazolines and uses thereof (2006-11-07),
12. 7115589 - Purine derivatives (2006-10-03),
13. 7019139 - Quinolinones and uses thereof (2006-03-28),
14. 7009054 - Quinolines and uses thereof (2006-03-07),
15. 6713462 - Quinolinones and uses thereof (2004-03-30),

Title: Innovations by Rajeswari Sundaramoorthi in Kinase Inhibitor Research

Introduction

Rajeswari Sundaramoorthi, based in Watertown, MA, is an accomplished inventor with a remarkable portfolio of 19 patents. His work has primarily focused on the development of innovative compounds that play a significant role in kinase inhibition, showcasing his contributions to medicinal chemistry and pharmaceuticals.

Latest Patents

Among Sundaramoorthi's latest inventions are two notable patents:

- **Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors**: This innovation pertains to compounds characterized by a specific general formula, offering potential in the treatment of various diseases by targeting kinases.

- **Acetylenic heteroaryl compounds**: Another significant invention that relates to compounds of a particular general formula, these acetylenic heteroaryl compounds are poised to contribute further to advancements in pharmaceutical applications.

Career Highlights

Sundaramoorthi's career is marked by his association with Ariad Pharmaceuticals, Inc., where he has the opportunity to contribute to cutting-edge research and development in the field of oncology and related therapies. His innovative work has positioned him as a key player within the organization, pushing the boundaries of what's possible in therapeutic interventions.

Collaborations

Throughout his career, Sundaramoorthi has collaborated with several notable professionals in the field, including William C. Shakespeare and Tomi K. Sawyer. These partnerships not only enhance the breadth of his research but also foster an environment of innovation, allowing for the cross-pollination of ideas and expertise.

Conclusion

Rajeswari Sundaramoorthi's contributions to the field of medicinal chemistry, particularly in kinase inhibitors, are noteworthy. With his impressive track record of patents and collaborations, he continues to make significant strides in developing compounds that promise to improve therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…